Actelion To Appeal US Verdict In Asahi Kasei Licencing Dispute – NASDAQ

ZURICH -(Dow Jones)- Swiss biotech Actelion Ltd (ATLN.VX ... and the trial court's judgment are neither supported by the facts nor correct as a matter of law." Actelion said it "strongly believes there are significant grounds for a successful appeal."
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>